132 related articles for article (PubMed ID: 9949905)
41. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
42. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
Vaughan HA; Svobodova S; Macgregor D; Sturrock S; Jungbluth AA; Browning J; Davis ID; Parente P; Chen YT; Stockert E; St Clair F; Old LJ; Cebon J
Clin Cancer Res; 2004 Dec; 10(24):8396-404. PubMed ID: 15623618
[TBL] [Abstract][Full Text] [Related]
44. [Immunohistochemistry characterization of neurocytoma of the cerebral hemispheres].
Korshunov AG; Sycheva RV; Golanov AV
Arkh Patol; 1997; 59(1):51-7. PubMed ID: 9139609
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
[TBL] [Abstract][Full Text] [Related]
46. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
47. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
48. Tumor antigen expression in melanoma varies according to antigen and stage.
Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087
[TBL] [Abstract][Full Text] [Related]
49. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms.
Sellheyer K; Krahl D
J Cutan Pathol; 2008 Apr; 35(4):366-72. PubMed ID: 18333896
[TBL] [Abstract][Full Text] [Related]
50. Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck.
Bartel-Friedrich S; Friedrich RE; Holzhausen HJ
Anticancer Res; 2000; 20(6D):4931-40. PubMed ID: 11326642
[TBL] [Abstract][Full Text] [Related]
51. [Glial tumors of the brain: current aspects of their classification and bases for genetic predisposition].
Anan'eva II; Malkarov MS; Korsakova NA; Balkanov AS; Dorofeev AE; Kachkov IA; Suchkov SV
Arkh Patol; 2007; 69(1):54-60. PubMed ID: 19385137
[TBL] [Abstract][Full Text] [Related]
52. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.
Latza U; Niedobitek G; Schwarting R; Nekarda H; Stein H
J Clin Pathol; 1990 Mar; 43(3):213-9. PubMed ID: 1692040
[TBL] [Abstract][Full Text] [Related]
53. [Epithelial membrane markers. Evaluation, presentation of one's own monoclonal antibodies and range of application in histopathology].
Möller P; Momburg F; Moldenhauer G
Verh Dtsch Ges Pathol; 1986; 70():116-26. PubMed ID: 3825248
[No Abstract] [Full Text] [Related]
54. [Problems of the immunohistochemical differential diagnosis of neuroendocrine carcinoma and neuroblastomas].
Okabe H; Okubo T; Adachi H; Ishikawa T; Iwai M; Miyahira Y; Ochi Y
Rinsho Byori; 1997 Sep; 45(9):850-5. PubMed ID: 9311258
[TBL] [Abstract][Full Text] [Related]
55. The role of immunocytochemical assays in the diagnosis of stereotactic biopsies from intracranial tumors.
Mottolese M; Carapella CM; De Santis M; Mastrostefano R; Raus L; Salzano M; Pericoli N; Riccio A; Natali PG
J Neurosurg Sci; 1990; 34(3-4):223-5. PubMed ID: 2098500
[TBL] [Abstract][Full Text] [Related]
56. [Significance of monoclonal antibodies in diagnosis and therapy of tumors of the central nervous system].
Lippitz BE; Kiessling M; Ostertag CB; Bigner DD
Nervenarzt; 1990 Oct; 61(10):587-96. PubMed ID: 2274091
[No Abstract] [Full Text] [Related]
57. Melanoma-associated antigens in tumours of the nervous system: an immunohistochemical study with the monoclonal antibody HMB-45.
Zimmer C; Gottschalk J; Goebel S; Cervos-Navarro J
Virchows Arch A Pathol Anat Histopathol; 1992; 420(2):121-6. PubMed ID: 1549900
[TBL] [Abstract][Full Text] [Related]
58. [Immunology of brain tumors: the glial carcino-fetal antigen].
Trouillas P
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):819-28. PubMed ID: 4340548
[No Abstract] [Full Text] [Related]
59. [Malignant lymphomas expressing an epithelial membrane antigen. Value in the immunohistochemical diagnosis of tumors].
Delsol G; Gatter K; Al Saati T; Stein H; Mason D
Arch Anat Cytol Pathol; 1985; 33(5-6):319. PubMed ID: 4091601
[No Abstract] [Full Text] [Related]
60. Primary brain tumors: tumor immunity and immunocompetence.
Mavligit GM; Gutterman JU; Hersh EM
Surg Neurol; 1973 Sep; 1(5):261-3. PubMed ID: 4353433
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
